ES2291349T3 - Derivados de acridina y su uso como medicamentos. - Google Patents

Derivados de acridina y su uso como medicamentos. Download PDF

Info

Publication number
ES2291349T3
ES2291349T3 ES01969410T ES01969410T ES2291349T3 ES 2291349 T3 ES2291349 T3 ES 2291349T3 ES 01969410 T ES01969410 T ES 01969410T ES 01969410 T ES01969410 T ES 01969410T ES 2291349 T3 ES2291349 T3 ES 2291349T3
Authority
ES
Spain
Prior art keywords
alkyl
radical
amino
alkoxy
substituted once
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01969410T
Other languages
English (en)
Spanish (es)
Inventor
Peter Emig
Eckhard Gunther
Silke Baasner
Gerald Bacher
Thomas Beckers
Beate Aue
Bernd Nickel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeterna Zentaris GmbH
Original Assignee
Aeterna Zentaris GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris GmbH filed Critical Aeterna Zentaris GmbH
Application granted granted Critical
Publication of ES2291349T3 publication Critical patent/ES2291349T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES01969410T 2000-07-21 2001-07-18 Derivados de acridina y su uso como medicamentos. Expired - Lifetime ES2291349T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035927 2000-07-21
DE10035927A DE10035927A1 (de) 2000-07-21 2000-07-21 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ES2291349T3 true ES2291349T3 (es) 2008-03-01

Family

ID=7649979

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01969410T Expired - Lifetime ES2291349T3 (es) 2000-07-21 2001-07-18 Derivados de acridina y su uso como medicamentos.

Country Status (28)

Country Link
US (1) US6706722B2 (enExample)
EP (1) EP1301485B1 (enExample)
JP (1) JP2004504382A (enExample)
KR (1) KR20030022296A (enExample)
CN (1) CN1296359C (enExample)
AR (1) AR033383A1 (enExample)
AT (1) ATE365717T1 (enExample)
AU (2) AU2001289675B2 (enExample)
BG (1) BG107507A (enExample)
BR (1) BR0112591A (enExample)
CA (1) CA2353360A1 (enExample)
CY (1) CY1106890T1 (enExample)
CZ (1) CZ2003427A3 (enExample)
DE (2) DE10035927A1 (enExample)
DK (1) DK1301485T3 (enExample)
ES (1) ES2291349T3 (enExample)
HU (1) HUP0303729A3 (enExample)
IL (1) IL153476A0 (enExample)
MX (1) MXPA02012564A (enExample)
NO (1) NO324939B1 (enExample)
NZ (1) NZ524155A (enExample)
PL (1) PL358808A1 (enExample)
PT (1) PT1301485E (enExample)
RU (1) RU2267488C2 (enExample)
SK (1) SK1932003A3 (enExample)
UA (1) UA75085C2 (enExample)
WO (1) WO2002008194A1 (enExample)
ZA (1) ZA200210411B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
BR0312294A (pt) * 2002-06-29 2005-04-12 Zentaris Gmbh Arilcarbonil piperazinas e hteroarilcarbonilpiperazinas e o uso das mesmas para tratamento de doenças benignas e malignas
AU2003232785A1 (en) * 2002-07-17 2004-02-02 Zentaris Gmbh Novel anthracene derivatives and the use thereof as a medicament
US7125461B2 (en) * 2003-05-07 2006-10-24 L & L Products, Inc. Activatable material for sealing, baffling or reinforcing and method of forming same
PE20050226A1 (es) * 2003-06-04 2005-05-18 Aventis Pharma Sa Productos aril-heteroaromaticos y composiciones que los contienen
FR2855825B1 (fr) * 2003-06-04 2008-08-22 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
US7249415B2 (en) * 2003-06-26 2007-07-31 Zephyros, Inc. Method of forming members for sealing or baffling
DE10331500A1 (de) * 2003-07-11 2005-02-24 Zentaris Gmbh Neue Acridin-Derivate und deren Verwendung als Arzneimittel
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
CN101146800A (zh) * 2005-01-27 2008-03-19 生物工程大学精神物质实验室 用于治疗阿尔茨海默病的有机化合物，它们的用途和制备方法
EP2125750B1 (en) * 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009017671A1 (en) * 2007-07-26 2009-02-05 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) * 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
CA2715290A1 (en) * 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009117109A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5301563B2 (ja) * 2008-05-01 2013-09-25 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
EP2291373B1 (en) * 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291371B1 (en) 2008-05-01 2015-06-10 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PL2324018T3 (pl) 2008-07-25 2014-02-28 Boehringer Ingelheim Int Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5679997B2 (ja) 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
KR20120061771A (ko) * 2009-04-30 2012-06-13 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
WO2012059416A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
EP0318235A3 (en) * 1987-11-25 1991-05-02 Takeda Chemical Industries, Ltd. Paf antagonist, 1,4-disubstituted piperazine compounds and production thereof
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
RU2126001C1 (ru) * 1995-01-10 1999-02-10 Самдзин Фармасьютикал Ко., Лтд Производные пиперазина и фармацевтическая композиция на их основе
RU2146254C1 (ru) * 1996-06-29 2000-03-10 Самдзин Фармасьютикал Ко., Лтд. Производные пиперазина и способ их получения
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
EP1107758A2 (en) 1998-08-28 2001-06-20 Scios Inc. Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
WO2000051614A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferases

Also Published As

Publication number Publication date
CN1296359C (zh) 2007-01-24
EP1301485B1 (de) 2007-06-27
IL153476A0 (en) 2003-07-06
HUP0303729A3 (en) 2009-01-28
CN1443172A (zh) 2003-09-17
CA2353360A1 (en) 2002-01-21
PL358808A1 (en) 2004-08-23
SK1932003A3 (en) 2003-10-07
BR0112591A (pt) 2003-07-22
PT1301485E (pt) 2007-08-30
US20020132821A1 (en) 2002-09-19
US6706722B2 (en) 2004-03-16
EP1301485A1 (de) 2003-04-16
DK1301485T3 (da) 2007-11-05
AR033383A1 (es) 2003-12-17
WO2002008194A8 (de) 2003-05-08
NO20030301D0 (no) 2003-01-20
RU2267488C2 (ru) 2006-01-10
JP2004504382A (ja) 2004-02-12
WO2002008194A1 (de) 2002-01-31
BG107507A (bg) 2003-09-30
NO324939B1 (no) 2008-01-07
HUP0303729A2 (hu) 2004-03-01
DE10035927A1 (de) 2002-03-07
HK1057549A1 (en) 2004-04-08
NO20030301L (no) 2003-03-11
CZ2003427A3 (cs) 2003-06-18
CY1106890T1 (el) 2012-09-26
UA75085C2 (en) 2006-03-15
MXPA02012564A (es) 2003-09-22
ZA200210411B (en) 2003-02-26
AU8967501A (en) 2002-02-05
KR20030022296A (ko) 2003-03-15
NZ524155A (en) 2005-04-29
ATE365717T1 (de) 2007-07-15
AU2001289675B2 (en) 2005-04-07
DE50112669D1 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
ES2291349T3 (es) Derivados de acridina y su uso como medicamentos.
SK1942003A3 (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents
Gao et al. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives
CN114174281A (zh) 细胞周期蛋白依赖性激酶7(cdk7)的降解剂及其用途
ES2441115T3 (es) Derivados de CBI sujetos a activación reductora
ES2303532T3 (es) Nuevos derivados de indol y su uso como medicamentos.
CN110563624A (zh) 具有抑癌活性的2-丙酮基硒基苯甲酰胺类化合物及用途
CN104844563A (zh) 一类靶向stat3的抑制剂及其应用
CN109081813A (zh) 一类苯并杂环类化合物及其治疗癌症的用途
AU2019318046B2 (en) Histone demethylase 5 inhibitors and uses thereof
CN107513089B (zh) 一种新型胞苷衍生物二聚体及其应用
Wang et al. Linker-modified triamine-linked acridine dimers: Synthesis and cytotoxicity properties in vitro and in vivo
US11712434B2 (en) Compound having anti-cancer effect, and preparation method therefor and use thereof
US20100069443A1 (en) Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
TWI722106B (zh) 具有抗癌活性之嘌呤化合物
JP2005537258A (ja) 新規アントラセン誘導体及び医薬品としてのその使用
TW201922690A (zh) 環－amp反應元素結合蛋白的抑制劑
CN110167917B (zh) 一种具有抗癌作用的化合物及其制备方法和应用
CN1982313B (zh) 10位取代基上含多个有机羧酸基团的喜树碱化合物及其制法与组合物
CN113234090B (zh) 靶向泛素化降解FoxM1的化合物或其可药用的盐、制备方法及用途
CN116102468B (zh) 靶向人脂质运载蛋白2的先导化合物或其药学上可接受的盐及其制备方法与应用
TWI721255B (zh) 一種具有抗癌作用的化合物及其製備方法和應用（一）
TWI703134B (zh) 一種具有抗癌作用的化合物及其製備方法和應用（二）
EP3381910B1 (en) 4-oxo-4,5-dihydrothiazole derivative, preparation method and use thereof
CN120987942A (zh) 一种吴茱萸碱类偶联物及其应用